http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012021125-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0711c29fb2da9b1dd808f0dc5cbcc14f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f1fbe736f4062f9b9beffb5bea4129b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0bf63e0920f35c3604e91007ec20855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f922b8eabe8757f508a08ff024f136be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22064cb240a6b75c4f2cf99e63e189ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e6230c2d99fafed81e6289c14d051c0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0017
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07
filingDate 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e18fb779f7e7a5a526c18ecba07ce85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5baea6e53374b5199d76800523936eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89fa6b3172cc3e194ee56d55ebff9d2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3135ace9dda8bac6c390f68b399e66f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2745caa0c755233695853040926d4563
publicationDate 2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012021125-A1
titleOfInvention Medical prostheses having bundled and non-bundled regions
abstract The present embodiments provide an endoluminal prosthesis, such as a stent-graft, having a relatively low delivery profile. In one embodiment, the prosthesis comprises a membrane, and at least one stent having contracted and expanded states, where the stent is coupled to the membrane and maintains patency in the expanded state. The prosthesis further may comprise selectively oriented axial and/or circumferential fibers arranged at predetermined locations along the length and circumference of the prosthesis. An increased population density of the circumferential and/or axial fibers may be provided in areas in which the at least one stent portion is attached to the membrane, or in areas of higher physiological loads imposed upon the endoluminal prosthesis. Selectively orienting axial fibers and circumferential fibers at predetermined locations along the length and circumference of the prosthesis, but not continuously along the entire prosthesis, significantly reduces delivery profile due to the reduction in graft material.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463101-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013151793-A1
priorityDate 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5925074-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070992-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009163951-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127513099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451651832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408

Total number of triples: 37.